Literature DB >> 15478061

Viral polymorphism in human papillomavirus types 33 and 35 and persistent and transient infection in the genital tract of women.

Simon Gagnon1, Catherine Hankins, Cécile Tremblay, Pierre Forest, Karina Pourreaux, François Coutlée.   

Abstract

BACKGROUND: Genetic polymorphism in human papillomavirus (HPV)-33 and -35 was investigated in 1055 sexually active women (732 human immunodeficiency virus [HIV] seropositive and 323 HIV seronegative).
METHODS: Consecutive genital specimens obtained at 6-month intervals were screened for HPV-33 and -35 by use of MY09-MY11. HPV-33 and -35 isolates from 95 women were analyzed by polymerase chain reaction sequencing of the long control region (LCR), E6, and E7.
RESULTS: For HPV-33, 101 (20%) of 506 nucleotides in the LCR were variable, compared with 10 (2.1%) of 483 nucleotides in E6 (P<.001) and 6 (1.9%) of 324 nucleotides in E7 (P<.001). For HPV-35, the proportion of variable nucleotide sites was similar between the LCR and both E6 (P=.54) and E7 (P=.33). The presence of a 78-base pair deletion in HPV-33 (relative risk [RR], 1.8 [95% confidence interval [CI], 1.2-2.7]) and the presence of nonsynonymous E7 variations in HPV-35 (RR, 2.6 [95% CI, 1.4-4.6]) were associated with persistence. When the data for HPV-33 and -35 were combined, infection by HPV isolates with nonsynonymous E7 variations (RR, 2.3 [95% CI, 1.6-3.4]; P=.001) and ethnicity (P=.04) were associated with persistence, whereas age (P = .14) and HIV infection/CD4 cell count status (P=.12) were not significantly associated with persistence, by logistic regression analysis.
CONCLUSION: HPV-33 and -35 polymorphism was different between types and was associated with persistence of HPV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15478061     DOI: 10.1086/424854

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes.

Authors:  Thibault Mesplède; David Gagnon; Fanny Bergeron-Labrecque; Ibrahim Azar; Hélène Sénéchal; François Coutlée; Jacques Archambault
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

2.  A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.

Authors:  Mark Schiffman; Ana Cecilia Rodriguez; Zigui Chen; Sholom Wacholder; Rolando Herrero; Allan Hildesheim; Rob Desalle; Brian Befano; Kai Yu; Mahboobeh Safaeian; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Martha Hutchinson; Diane Solomon; Philip E Castle; Robert D Burk
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

Review 3.  Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis.

Authors:  Anne F Rositch; Jill Koshiol; Michael G Hudgens; Hilda Razzaghi; Danielle M Backes; Jeanne M Pimenta; Eduardo L Franco; Charles Poole; Jennifer S Smith
Journal:  Int J Cancer       Date:  2012-10-11       Impact factor: 7.396

4.  Variant-specific persistence of infections with human papillomavirus Types 31, 33, 45, 56 and 58 and risk of cervical intraepithelial neoplasia.

Authors:  Long Fu Xi; Mark Schiffman; Laura A Koutsky; James P Hughes; Ayaka Hulbert; Zhenping Shen; Denise A Galloway; Nancy B Kiviat
Journal:  Int J Cancer       Date:  2016-05-14       Impact factor: 7.396

5.  Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer.

Authors:  Alyce A Chen; Daniëlle A M Heideman; Debby Boon; Zigui Chen; Robert D Burk; Hugo De Vuyst; Tarik Gheit; Peter J F Snijders; Massimo Tommasino; Silvia Franceschi; Gary M Clifford
Journal:  Virology       Date:  2013-11-12       Impact factor: 3.616

6.  Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67.

Authors:  Zigui Chen; Mark Schiffman; Rolando Herrero; Rob Desalle; Kathryn Anastos; Michel Segondy; Vikrant V Sahasrabuddhe; Patti E Gravitt; Ann W Hsing; Robert D Burk
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

7.  Ano-genital human papillomavirus type 97 infection is detected in Canadian men but not women at risk or infected with the human immunodeficiency virus.

Authors:  Marie-Eve Landry; Irving E Salit; Catherine Rodrigues-Coutlée; Deborah Money; Anu Rebbapragada; Jill Tinmouth; Catherine Hankins; Isabelle Gorska-Flipot; Jacques Archambault; Eduardo L Franco; François Coutlée
Journal:  Virol J       Date:  2012-10-23       Impact factor: 4.099

8.  Prevalence and predictors of Pap smear cervical epithelial cell abnormality among HIV-positive and negative women attending gynecological examination in cervical cancer screening center at Debre Markos referral hospital, East Gojjam, Northwest Ethiopia.

Authors:  Melkamu Getinet; Baye Gelaw; Abinet Sisay; Eiman A Mahmoud; Abate Assefa
Journal:  BMC Clin Pathol       Date:  2015-09-23

9.  Genetic variations of E6 and long control region of human papillomavirus type 16 from patients with cervical lesion in Liaoning, China.

Authors:  Zhengrong Sun; Zhitao Lu; Jianhua Liu; Guili Wang; Weiqiang Zhou; Lianxia Yang; Chao Liu; Bo Wang; Qiang Ruan
Journal:  BMC Cancer       Date:  2013-10-07       Impact factor: 4.430

10.  Human papillomavirus variants among Inuit women in northern Quebec, Canada.

Authors:  Barbara Gauthier; Francois Coutlée; Eduardo L Franco; Paul Brassard
Journal:  Int J Circumpolar Health       Date:  2015-12-09       Impact factor: 1.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.